Adjustable high-transdermal-rate herbal composite polypeptide and application thereof in hair loss prevention and hair growth

Through the liposome technology of encapsulating blue copper peptides, combined with polyglycerol fatty acid ester and arboriculata extract, the problem of the difficulty of polypeptide penetration into the dermis in the prior art is solved, and effective treatment of androgenic alopecia is achieved, promoting the promotion of androgenic hair loss. Hair follicles are nutritious and hair growth, which significantly prevents hair loss.

CN119033615APending Publication Date: 2024-11-29HANGZHOU PEPTIDE BIOCHEM +2

Patent Information

Application Number
CN202411062559.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-04-24
Publication Date
2024-11-29

AI Technical Summary

Technical Problem

The prior art is difficult to effectively treat androgenic hair loss, and conventional water-soluble polypeptides are difficult to penetrate into the dermis and cannot effectively develop hair. In the past inventions, they mainly emphasize scalp nourishment but fail to clarify the efficient application of preventing hair loss.

Method used

Liposomes encapsulated by blue copper peptides are used to combine blue copper peptides with arborite extract through polyglycerol fatty acid ester encapsulation technology, and micronomial droplets are prepared by thermal spray to form microspheres that can penetrate deep into the dermis. Promote vascular regeneration and hair follicle nutrition, and inhibit the problem of excessive secretion of fat on the scalp.

Benefits of technology

It has achieved improved expression of hair growth factor, good cell proliferation effect, high testosterone reduction efficiency, significant oil control effect, excellent skin permeability, thickened hair diameter, increased hair during growth period, and reduced hair during rest period, effectively preventing hair loss.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119033615A_ABST
    Figure CN119033615A_ABST
Patent Text Reader

Abstract

The invention discloses an adjustable high-transdermal-rate herbal composite polypeptide and an application thereof in hair loss prevention and hair growth, belongs to the technical field of liposomes, and particularly relates to a blue-copper peptide encapsulated liposome, which comprises a core material comprising blue-copper peptide; the encapsulating material encapsulates the core material; the encapsulating material comprises polyglycerol fatty acid ester. A core material containing the blue copper peptide and / or the platycladus orientalis extract and an encapsulating material containing polyglycerol fatty acid ester are prepared into the liposome encapsulating the blue copper peptide and / or the platycladus orientalis extract. The liposome encapsulating the blue copper peptide and / or the platycladus orientalis extract, prepared by the invention, has the effects of improving the expression of hair growth promoting factors, having a good cell proliferation effect, good testosterone reduction efficiency, good oil control effect, good skin permeability, increasing hair diameter, increasing hair in a growing period, reducing hair in a resting period, preventing alopecia and the like.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of liposomes, and in particular relates to an adjustable herbal composite polypeptide with high skin penetration rate and an application thereof in preventing hair loss and promoting hair growth. Background Art

[0002] As people age, the prevalence of hair loss increases, which has a significant impact on the quality of life of patients. The most common types of hair loss include androgenic alopecia (AGA) and seborrheic alopecia. Effective treatment for AGA is a direction worth further investigation. Unfortunately, there are currently few specific drugs that can be used to treat hair growth in patients with hair loss. Many current methods are limited to inhibiting the phenomenon of hair loss, that is, preventing hair loss. However, patients who have already started to lose hair or have thinning hair still have problems.

[0003] The etiology of hair loss is multifactorial. Hormonal imbalance, genetic predisposition, insufficient blood flow to the scalp, and loss of extracellular matrix proteins in the follicular bed are considered to be the main predisposing factors for hair loss. The hair follicle is an important unit of hair proliferation and differentiation and is a dynamic micro-organ composed of different cell populations associated with ectodermal, mesodermal, and neural crest origins. Hair follicles rely on specialized dermal and stromal cells located at the base for circulation and regeneration. In addition, several cytokines and growth factors, such as vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), epidermal growth factor (EGF), insulin-like growth factor-1 (IGF-1), and transforming growth factor-β1 (TGF-β1), are known to be involved in regulating hair morphogenesis and the growth of specialized dermal cells.

[0004] CN110151592A discloses a composition and its preparation method and use, lists a variety of polypeptides with potential hair growth ability, considers its stimulation and restoration of capillaries, so as to achieve the effect of hair growth, but the process omits the key scenario that conventional water-soluble polypeptides are difficult to penetrate into the dermis, and it is also difficult to enter the hair follicles blocked by oil to play a nourishing effect, and fails to provide good skin penetration promotion techniques. In addition, in the past inventions, the main purpose is to nourish the scalp to prevent hair loss. CN115590793A discloses a Chinese medicine shampoo and conditioner for improving the sub-health state of scalp and hair, and its preparation method and application, which emphasizes the nourishing effect of various Chinese herbal medicines mainly based on Platycladus orientalis on the scalp, so as to achieve the purpose of black hair and moisturizing; CN112603844A discloses a frozen powder capable of quickly generating blue copper peptide and its preparation method, which emphasizes the preparation method of blue copper peptide, and the explanation of its reasonable and efficient application in preventing hair loss and hair growth is not clear enough. Summary of the invention

[0005] The present invention mainly emphasizes the scientific combination of blue copper peptide and Platycladus orientalis extract, relying on the penetration-promoting ability of blue copper peptide encapsulation technology to efficiently reach the dermis to stimulate blood vessel regeneration, and is used to treat hair loss problems in patients with hair follicle atrophy. While emphasizing gentle hair growth, the combined use of the two compositions inhibits the high aggregation of Propionibacterium acnes and Malassezia on the scalp, solving the problem of excessive scalp oil secretion blocking the hair follicle opening.

[0006] The present invention focuses on verifying its role in angiogenesis and nutrition supply to hair follicles. Conventional blue copper peptides, due to their hydrophilic characteristics, stay on the scalp surface during daily application and are difficult to penetrate the stratum corneum into the dermis to exert their effects. In addition, during the penetration process, enzymes in the human body will degrade blue copper peptides.

[0007] There are many studies on the mechanism of action of Platycladus orientalis leaves, and the conclusions are different. The present invention finds that the Platycladus orientalis extract alone has no effect on promoting hair growth.

[0008] The object of the present invention is to provide a liposome encapsulating blue copper peptide or a composition thereof, which has the properties of improving the expression of hair growth promoting factors, good cell proliferation effect, good testosterone reduction efficiency, good oil control effect, good skin permeability, thickening hair diameter, increasing the number of hair in the growth phase, reducing the number of hair in the resting phase, and preventing hair loss, and the use of the liposome in hair growth.

[0009] The technical solution adopted by the present invention to achieve the above-mentioned purpose is: A liposome encapsulating a blue copper peptide comprises: a core material, the core material comprises a blue copper peptide; and an encapsulating material encapsulating the core material; the encapsulating material comprises polyglycerol fatty acid ester, and the weight ratio of the blue copper peptide to the polyglycerol fatty acid ester is 1:1-300.

[0010] Preferably, the core material further comprises a Platycladus orientalis extract; or the encapsulating material further comprises a thickener.

[0011] More preferably, the weight ratio of the Platycladus orientalis extract to the blue copper peptide is 1:0.01-1000; or, the thickener includes at least one of sclerotium gum, sodium hyaluronate and xanthan gum.

[0012] More preferably, the amount of the thickener is 50-100 wt % of the polyglycerol fatty acid ester.

[0013] The invention discloses a method for preparing the above-mentioned liposome encapsulating blue copper peptide, comprising: preparing the liposome encapsulating blue copper peptide by using a core material sample liquid and an encapsulating material sample liquid by a thermal spraying method; the core material sample liquid contains blue copper peptide, the encapsulating material sample liquid contains polyglycerol fatty acid ester, and the weight ratio of blue copper peptide to polyglycerol fatty acid ester is 1:1-300.

[0014] The invention discloses a composition containing blue copper peptide liposomes, comprising the above-mentioned liposomes encapsulating the blue copper peptide.

[0015] Preferably, the composition further comprises an extract of Platycladus orientalis.

[0016] The invention discloses the use of the liposome encapsulating the blue copper peptide in preparing toiletries.

[0017] The invention discloses use of the composition containing blue copper peptide liposomes in preparing toiletries.

[0018] Preferably, in the preparation of the polyglycerol fatty acid ester solution, the polyglycerol fatty acid ester is added to ethanol and treated at 50-70° C. to prepare the polyglycerol fatty acid ester solution.

[0019] More preferably, in the preparation of the polyglycerol fatty acid ester solution, the polyglycerol fatty acid ester solution contains 1-6 wt % of polyglycerol fatty acid ester.

[0020] Preferably, in the preparation of the blue copper peptide sample solution, the blue copper peptide is added into water and treated at 20-45° C. to prepare the blue copper peptide sample solution.

[0021] More preferably, in the preparation of the blue copper peptide sample solution, the blue copper peptide sample solution contains 1-10wt% of blue copper peptide.

[0022] Preferably, in the preparation of blue copper peptide liposomes, liposomes are prepared by thermal spraying, and polyglycerol fatty acid ester solution and blue copper peptide sample liquid are mixed at the nozzle of thermal spraying by a microfluidic system, and thermal spraying is performed under high pressure to form micro-nano droplets, and polyglycerol fatty acid ester encapsulated particles are obtained after ethanol is completely volatilized, and then the polyglycerol fatty acid ester encapsulated particles are added to water, and then the polyglycerol fatty acid ester encapsulated particles are added to water, and then the polyglycerol fatty acid ester encapsulated microspheres are air-dried into polyglycerol fatty acid ester encapsulated microspheres, and then the polyglycerol fatty acid ester encapsulated microspheres are added to the thickening solution, and freeze-dried to obtain blue copper peptide liposomes. After freeze-drying, the product can be shaped according to the shape envisioned to obtain liposomes of different shapes. The skin delivery problem of conventional applications of blue copper peptides has always been a pain point for daily chemical products. Palmitoyl tripeptide-1 disclosed in CN202210547095.3 has beneficial skin delivery performance, but its solubility in water is extremely low. It can be dispersed in a glycerol system through certain operations, but the excessive introduction of glycerol is easy to provide a more suitable living environment for the imbalanced flora of the scalp, further exacerbating the risk of seborrheic alopecia. The present invention has found that polyglycerol fatty acid esters can be used as encapsulation materials to encapsulate core materials including blue copper peptides, which can solve the problem of skin delivery and avoid providing a more suitable living environment for unbalanced flora. The amount of polyglycerol fatty acid esters used has an important influence on skin delivery. It is necessary to regulate the quantitative relationship between the encapsulation material and the core material to achieve a better skin delivery effect. Otherwise, the effect is poor or even ineffective. Therefore, the present invention explores a suitable lipid encapsulation technology to successfully complete the deep skin delivery of blue copper peptides.

[0023] More preferably, during the thermal spray treatment, the wind heat environment in the heating jacket is 30-50°C, and the bottom of the heating jacket is provided with cooling water at 0-10°C.

[0024] More preferably, when mixing at the nozzle of the thermal spray, the mixing amount of the polyglycerol fatty acid ester solution and the blue copper peptide sample solution is 10-50:1 by volume, the liquid flow rate at the nozzle is 0.1-0.3 mL / s, and the air pressure at the nozzle is 2-5 bar.

[0025] More preferably, the polyglycerol fatty acid ester encapsulated particles are added into water at 0-10°C.

[0026] More preferably, the thickened solution is formed by mixing a thickener and water, the thickened solution contains 0.3-1 wt % of the thickener, and the thickener includes at least one of sclerotium gum, sodium hyaluronate and xanthan gum.

[0027] More preferably, when the polyglycerol fatty acid ester encapsulated microspheres are added to the thickening solution, the polyglycerol fatty acid ester encapsulated microspheres are based on the amount of polyglycerol fatty acid ester therein, and the amount of the thickener is 50-100wt% of the polyglycerol fatty acid ester.

[0028] Preferably, in the preparation of the Platycladus orientalis extract, the Platycladus orientalis raw material is added to an ethanol solution, heated under reflux extraction at 70-90°C for 2-5h, filtered and separated, and the filtrate is concentrated and dried to remove residual water to obtain the Platycladus orientalis extract.

[0029] More preferably, the Thuja orientalis raw material is one of crushed Thuja orientalis blocks, Thuja orientalis particles and Thuja orientalis powder or a mixture thereof.

[0030] More preferably, the ethanol solution contains 30-60 wt % of ethanol, and the amount of the Platycladus orientalis raw material used is 5-30 wt % of the ethanol solution.

[0031] More preferably, at least one of coarse filtration, adsorption filtration and fine filtration is used in the filtration separation. Coarse filtration is to remove the solid block or granular Platycladus orientalis residue after extraction treatment; adsorption filtration is a combined filtration of activated carbon and filter paper, in which the activated carbon is located above the filter paper, and the Platycladus orientalis extract is filtered and separated; fine filtration is filtration using a filter membrane with a pore size of 0.45 μm.

[0032] More preferably, the concentration is evaporation concentration, which can be a common evaporation process or a rotary evaporation process, the purpose of which is to remove the ethanol solvent. The purpose of drying is to remove water.

[0033] Preferably, butyl butyryl lactylate can also be added to the polyglycerol fatty acid ester solution. The polyglycerol fatty acid ester solution contains 0.1-0.4wt% butyl butyryl lactylate. The present invention also finds that butyl butyryl lactylate can be used as an encapsulating material, and when butyl butyryl lactylate and polyglycerol fatty acid ester are used together, a better skin delivery effect is achieved.

[0034] Preferably, in the preparation of the Platycladus orientalis extract sample solution, the Platycladus orientalis extract is added to water and treated at 20-45° C. to prepare the Platycladus orientalis extract sample solution.

[0035] More preferably, the Platycladus orientalis extract sample solution contains 1-10 wt % of Platycladus orientalis extract.

[0036] Preferably, in the preparation of Platycladus orientalis extract liposomes, the liposomes are prepared by thermal spraying, and the polyglycerol fatty acid ester solution and the Platycladus orientalis extract sample solution are mixed at the nozzle of the thermal spray through a microfluidic system, and thermal sprayed under high pressure to form micro-nano droplets, and polyglycerol fatty acid ester encapsulated particles are obtained after the ethanol is completely evaporated, and then the polyglycerol fatty acid ester encapsulated particles are added to water, recovered after solidification, and air-dried into polyglycerol fatty acid ester encapsulated microspheres, and then the polyglycerol fatty acid ester encapsulated microspheres are added to the thickening solution, freeze-dried, and the Platycladus orientalis extract liposomes are obtained.

[0037] More preferably, when mixing at the nozzle of the thermal spray, the mixing amount of the polyglycerol fatty acid ester solution and the Platycladus orientalis extract sample solution is 10-50:1 by volume, the liquid flow rate at the nozzle is 0.1-0.3 mL / s, and the air pressure at the nozzle is 2-5 bar.

[0038] Preferably, in the preparation of the composition sample solution, the blue copper peptide sample solution and the Platycladus orientalis extract sample solution are mixed to obtain the composition sample solution.

[0039] More preferably, the blue copper peptide sample solution and the Platycladus orientalis extract sample solution are mixed in a mass ratio of 1:0.1-100.

[0040] Preferably, in the preparation of the composition liposomes, the liposomes are prepared by thermal spraying, the polyglycerol fatty acid ester solution and the composition sample liquid are mixed at the nozzle of the thermal spray through a microfluidic system, and thermal spraying is performed under high pressure to form micro-nano droplets, and polyglycerol fatty acid ester encapsulated particles are obtained after the ethanol is completely evaporated, and then the polyglycerol fatty acid ester encapsulated particles are added to water, recovered after solidification, and air-dried into polyglycerol fatty acid ester encapsulated microspheres, and then the polyglycerol fatty acid ester encapsulated microspheres are added to the thickening solution, freeze-dried, and the composition liposomes are obtained.

[0041] More preferably, when mixing at the nozzle of the thermal spray, the mixing amount of the polyglycerol fatty acid ester solution and the composition sample solution is 10-50:1 by volume, the liquid flow rate at the nozzle is 0.1-0.3 mL / s, and the air pressure at the nozzle is 2-5 bar.

[0042] Preferably, in the preparation of the complex, the blue copper peptide liposome and the Platycladus orientalis extract sample solution are mixed to obtain the complex.

[0043] More preferably, the blue copper peptide liposome and the Platycladus orientalis extract sample solution are mixed in a mass ratio of 1:10-200.

[0044] More preferably, a diluent may be added to the composite to prepare the composite to a desired concentration. The diluent may be water, ethanol or other reagents that can be used in toiletries.

[0045] The present invention adopts a core material including blue copper peptide and / or Platycladus orientalis extract and an encapsulation material including polyglycerol fatty acid ester to prepare a liposome encapsulating blue copper peptide and / or Platycladus orientalis extract, so it has the following beneficial effects: it can improve the expression of hair growth promoting factors, has good cell proliferation effect, good testosterone reduction efficiency, good oil control effect, good skin permeability, thickening hair diameter, increasing hair in growth period, reducing hair in rest period, and preventing hair loss. Therefore, the present invention is a liposome encapsulating blue copper peptide or its composition, which has the performance of improving the expression of hair growth promoting factors, good cell proliferation effect, good testosterone reduction efficiency, good oil control effect, good skin permeability, thickening hair diameter, increasing hair in growth period, reducing hair in rest period, and preventing hair loss, and its use in hair growth. BRIEF DESCRIPTION OF THE DRAWINGS

[0046] Figure 1 This is the relative expression result of growth-promoting factors.

[0047] Figure 2 This is the absorbance graph after HaCaT cell proliferation.

[0048] Figure 3 This is a graph showing the effect of Platycladus orientalis extract on cell proliferation.

[0049] Figure 4 This is a graph showing the effect of blue copper peptide-like solution on cell proliferation.

[0050] Figure 5 This is a graph showing the effect of the combined sample solution on cell proliferation.

[0051] Figure 6 This is a diagram showing the results of a subcutaneous angiogenesis experiment.

[0052] Figure 7 This is the testosterone concentration signal result diagram after treatment with Platycladus orientalis extract sample solution.

[0053] Figure 8 This is the testosterone concentration signal result diagram after treatment with blue copper peptide sample solution.

[0054] Fig. 9 This is a testosterone concentration signal result diagram after treatment with the combined sample solution.

[0055] Fig.10 This is the result of cell lipid fluorescence intensity after treatment with Platycladus orientalis extract sample solution.

[0056] Fig.11 This is the result of cell lipid fluorescence intensity after treatment with blue copper peptide sample solution.

[0057] Fig.12 This is a graph showing the fluorescence intensity of cell lipids after treatment with the combined sample solution.

[0058] Fig.13 This is a graph showing the content of blue copper peptide in different skin layers.

[0059] Fig.14 This is a graph showing the content of blue copper peptide in the dermis.

[0060] Fig.15 Diameter of hair.

[0061] Fig.16 This is a diagram showing the proportion of hair in the growth phase.

[0062] Fig.17 This is a diagram showing the proportion of hair in the resting phase. DETAILED DESCRIPTION

[0063] The technical solution of the present invention is further described in detail below in conjunction with specific implementations and drawings: Example 1: A method for preparing liposomes encapsulating blue copper peptide Preparation of polyglycerol fatty acid ester solution: polyglycerol fatty acid ester is added into ethanol and treated at 60° C. to prepare polyglycerol fatty acid ester solution. The polyglycerol fatty acid ester solution contains 3 wt % of polyglycerol fatty acid ester.

[0064] Preparation of blue copper peptide sample solution: blue copper peptide is added into water and treated at 40° C. to prepare blue copper peptide sample solution. The blue copper peptide sample solution contains 5 wt% of blue copper peptide.

[0065] Preparation of blue copper peptide liposomes: Liposomes are prepared by thermal spraying. The polyglycerol fatty acid ester solution and the blue copper peptide sample solution are mixed at the nozzle of the thermal spray through a microfluidic system. Micro-nano droplets are formed by thermal spraying under high pressure. After the ethanol is completely evaporated, polyglycerol fatty acid ester encapsulated particles are obtained. Then the polyglycerol fatty acid ester encapsulated particles are added to water, recovered after solidification, air-dried into polyglycerol fatty acid ester encapsulated microspheres, and then the polyglycerol fatty acid ester encapsulated microspheres are added to the thickening solution, freeze-dried, and blue copper peptide liposomes are obtained. In the thermal spray treatment, the wind heat environment in the heating jacket is 40°C, and the bottom of the heating jacket is provided with 10°C cooling water. When mixed at the nozzle of the thermal spray, the mixing amount of the polyglycerol fatty acid ester solution and the blue copper peptide sample solution is a volume ratio of 30:1, the nozzle liquid flow rate is 0.2mL / s, and the nozzle air pressure is 3bar. The polyglycerol fatty acid ester encapsulated particles are added to 10°C water. The thickening solution is formed by mixing a thickener and water, wherein the thickening solution contains 0.6 wt % of the thickener, which is sclerotium gum. When the polyglycerol fatty acid ester encapsulated microspheres are added to the thickening solution, the polyglycerol fatty acid ester encapsulated microspheres are measured based on the amount of the polyglycerol fatty acid ester therein, and the amount of the thickener is 80 wt % of the polyglycerol fatty acid ester.

[0066] Example 2: A method for preparing liposomes encapsulating blue copper peptide The only difference between this embodiment and embodiment 1 is that the mixed amount of the polyglycerol fatty acid ester solution and the blue copper peptide sample solution is a volume ratio of 20:1.

[0067] Example 3: A method for preparing liposomes encapsulating blue copper peptide Compared with Example 1, the present embodiment is different in that the polyglycerol fatty acid ester solution is used.

[0068] Preparation of polyglycerol fatty acid ester solution: polyglycerol fatty acid ester and butyl butyryl lactylate are added to ethanol and treated at 60° C. to prepare a polyglycerol fatty acid ester solution. The polyglycerol fatty acid ester solution contains 3 wt% of polyglycerol fatty acid ester and 0.15 wt% of butyl butyryl lactylate.

[0069] Example 4: A method for preparing liposomes encapsulating blue copper peptide Compared with Example 1, the present embodiment is different in that the polyglycerol fatty acid ester solution is used.

[0070] Preparation of polyglycerol fatty acid ester solution: polyglycerol fatty acid ester and butyl butyryl lactylate are added to ethanol and treated at 60° C. to prepare polyglycerol fatty acid ester solution. The polyglycerol fatty acid ester solution contains 3 wt% of polyglycerol fatty acid ester and 0.3 wt% of butyl butyryl lactylate.

[0071] Example 5: A method for preparing liposomes encapsulating Platycladus orientalis extract Preparation of Platycladus orientalis extract: Add Platycladus orientalis raw material to ethanol solution, heat and reflux extraction at 80℃ for 3h, filter and separate, concentrate and dry the filtrate to remove the remaining water, and obtain Platycladus orientalis extract. Platycladus orientalis raw material is Platycladus orientalis block after crushing. The ethanol solution contains 50wt% ethanol, and the amount of Platycladus orientalis raw material used is 20wt% of the ethanol solution. Rough filtration, adsorption filtration and fine filtration are used in filtration and separation. Rough filtration is to remove the solid block Platycladus orientalis residue after extraction; adsorption filtration is a combined filtration of activated carbon and filter paper, and the activated carbon is located above the filter paper to filter and separate the Platycladus orientalis extract; fine filtration is to filter with a filter membrane with a pore size of 0.45μm. Concentration is evaporation concentration, which can be ordinary evaporation or rotary evaporation, and the purpose is to remove ethanol solvent. The purpose of drying is to remove water.

[0072] Preparation of Platycladus orientalis extract sample solution: Platycladus orientalis extract was added into water and treated at 40° C. to prepare Platycladus orientalis extract sample solution. The Platycladus orientalis extract sample solution contained 5 wt % of Platycladus orientalis extract.

[0073] Preparation of Platycladus orientalis extract liposomes: Liposomes were prepared by thermal spraying. The polyglycerol fatty acid ester solution and Platycladus orientalis extract sample solution were mixed at the nozzle of thermal spraying through a microfluidic system, and micro-nano droplets were formed by thermal spraying under high pressure. After the ethanol was completely volatilized, polyglycerol fatty acid ester encapsulated particles were obtained, and then the polyglycerol fatty acid ester encapsulated particles were added to water, recovered after solidification, air-dried into polyglycerol fatty acid ester encapsulated microspheres, and then the polyglycerol fatty acid ester encapsulated microspheres were added to the thickening solution, freeze-dried, and Platycladus orientalis extract liposomes were obtained. During the thermal spraying treatment, the wind heat environment in the heating jacket was 40°C, and the bottom of the heating jacket was provided with 10°C cooling water. When mixed at the nozzle of the thermal spraying, the mixing amount of the polyglycerol fatty acid ester solution and the Platycladus orientalis extract sample solution was 30:1 by volume, the liquid flow rate at the nozzle was 0.2mL / s, and the air pressure at the nozzle was 3bar. The polyglycerol fatty acid ester encapsulated particles were added to 10°C water. The thickening solution is formed by mixing a thickener and water, and the thickening solution contains 0.6wt% of the thickener, which is sclerotium gum. When the polyglycerol fatty acid ester encapsulated microspheres are added to the thickening solution, the polyglycerol fatty acid ester encapsulated microspheres are based on the amount of polyglycerol fatty acid ester therein, and the amount of the thickener is 80wt% of the polyglycerol fatty acid ester. The polyglycerol fatty acid ester solution is taken from Example 1.

[0074] Example 6: A method for preparing liposomes encapsulating Platycladus orientalis extract The only difference between this embodiment and embodiment 3 is that the mixing amount of the polyglycerol fatty acid ester solution and the Platycladus orientalis extract sample solution is 20:1 in volume ratio.

[0075] Example 7: A method for preparing a composite liposome Preparation of the composite sample solution: Mix the blue copper peptide sample solution and the Platycladus orientalis extract sample solution to obtain the composite sample solution. The blue copper peptide sample solution and the Platycladus orientalis extract sample solution are mixed at a mass ratio of 1:10. The blue copper peptide sample solution is taken from Example 1, and the Platycladus orientalis extract sample solution is taken from Example 3.

[0076] Preparation of composition liposomes: Liposomes are prepared by thermal spraying. The polyglycerol fatty acid ester solution and the composition sample liquid are mixed at the nozzle of the thermal spray through a microfluidic system, and the micro-nano droplets are formed by thermal spraying under high pressure. After the ethanol is completely volatilized, polyglycerol fatty acid ester encapsulated particles are obtained, and then the polyglycerol fatty acid ester encapsulated particles are added to water, recovered after solidification, air-dried into polyglycerol fatty acid ester encapsulated microspheres, and then the polyglycerol fatty acid ester encapsulated microspheres are added to the thickening solution, freeze-dried, and the composition liposomes are obtained. In the thermal spraying treatment, the wind heat environment in the heating jacket is 40°C, and the bottom of the heating jacket is provided with 10°C cooling water. When mixed at the nozzle of the thermal spray, the mixing amount of the polyglycerol fatty acid ester solution and the composition sample liquid is a volume ratio of 30:1, the nozzle liquid flow rate is 0.2mL / s, and the nozzle air pressure is 3bar. The polyglycerol fatty acid ester encapsulated particles are added to 10°C water. The thickening solution is a mixture of a thickener and water, and the thickening solution contains 0.6wt% of a thickener, and the thickener is sclerotium gum. When the polyglycerol fatty acid ester encapsulated microspheres are added to the thickening solution, the polyglycerol fatty acid ester encapsulated microspheres are based on the amount of polyglycerol fatty acid ester therein, and the amount of the thickener is 80wt% of the polyglycerol fatty acid ester. The polyglycerol fatty acid ester solution is taken from Example 1.

[0077] Example 8: A method for preparing a composite liposome The only difference between this embodiment and embodiment 5 is that the mixed amount of the polyglycerol fatty acid ester solution and the composition sample solution is a volume ratio of 20:1.

[0078] Example 9: A method for preparing a composite Preparation of the complex: blue copper peptide liposomes and a sample solution of Platycladus orientalis extract are mixed to obtain a complex. The blue copper peptide liposomes and the sample solution of Platycladus orientalis extract are mixed at a mass ratio of 1:30. The blue copper peptide liposomes are taken from Example 1, and the sample solution of Platycladus orientalis extract is taken from Example 3. A diluent may also be added to the complex to prepare a desired concentration. The diluent is water.

[0079] Example 10: A method for preparing a composite Preparation of the complex: blue copper peptide liposomes and a sample solution of Platycladus orientalis extract are mixed to obtain a complex. The blue copper peptide liposomes and the sample solution of Platycladus orientalis extract are mixed at a mass ratio of 1:80. The blue copper peptide liposomes are taken from Example 1, and the sample solution of Platycladus orientalis extract is taken from Example 3. A diluent may also be added to the complex to prepare a desired concentration. The diluent is water.

[0080] Comparative Example 1: A method for preparing a composite sample solution Preparation of the composite sample solution: Mix the blue copper peptide sample solution and the Platycladus orientalis extract sample solution to obtain the composite sample solution. The blue copper peptide sample solution and the Platycladus orientalis extract sample solution are mixed at a mass ratio of 1:1. The blue copper peptide sample solution is taken from Example 1, and the Platycladus orientalis extract sample solution is taken from Example 3.

[0081] Comparative Example 2: A method for preparing liposomes encapsulating blue copper peptide The only difference between this comparative example and Example 1 is that in the preparation of the blue copper peptide liposome, no sclerotium gum is added to the thickening solution in the preparation of the blue copper peptide liposome.

[0082] Comparative Example 3: A method for preparing liposomes encapsulating blue copper peptide The only difference between this comparative example and Example 1 is that in the preparation of the blue copper peptide liposome, the mixing amount of the polyglycerol fatty acid ester solution and the blue copper peptide sample solution is 5:1 by volume.

[0083] Comparative Example 4: A method for preparing liposomes encapsulating blue copper peptide The only difference between this comparative example and Example 1 is that in the preparation of the blue copper peptide liposome, the mixing amount of the polyglycerol fatty acid ester solution and the blue copper peptide sample solution is 60:1 by volume.

[0084] Comparative Example 5: A method for preparing liposomes encapsulating blue copper peptide The only difference between this comparative example and Example 1 is the polyglycerol fatty acid ester solution, in which the content of butyl butyryl lactylate is 0.05 wt %.

[0085] Comparative Example 6: A method for preparing liposomes encapsulating blue copper peptide The only difference between this comparative example and Example 1 is the polyglycerol fatty acid ester solution, in which the content of butyl butyryl lactylate is 0.5 wt %.

[0086] Test example: 1. Relative expression experiment of growth promoting factors This experiment used the Quanti Gene Plex (QGP) method based on the Luminex 200 suspension chip multiplex detection system, combined with the detection of branched DNA technology, to directly measure RNA transcripts through signal amplification.

[0087] In this study, dermal papilla cells were used, and 6 × 10 4 The density of cells was plated in a 24-well plate, and the volume of each well was 0.5 ml. The cell well plate was cultured in an incubator for 24 hours. This experiment was divided into three groups, each containing 3 replicate wells, namely the control group, the first group, and the second group.

[0088] After 24 hours of culture, the supernatant was removed and 0.2 ml of cell lysis solution was added to the well plate containing the dermal papilla cells to lyse the cells. The lysed cells were stored at -80°C.

[0089] In this experiment, the blue copper peptide sample solution prepared in Example 1 and the Platycladus orientalis extract sample solution prepared in Example 3 were mixed and compounded, and water was used as a diluent to prepare the following test samples: in the first group, the Platycladus orientalis extract in the test sample solution was 0.55wt%, and the concentration of blue copper peptide was 60ppm; in the second group, when the Platycladus orientalis extract in the test sample solution was 0.25wt%, the concentration of blue copper peptide was 30ppm. In the experiment, human keratinocytes in the hair loss group were used as the control group, and no blue copper peptide and Platycladus orientalis extract were added to the control group. In this experiment, water was used as a diluent for the test sample solution. When the test sample is used at the above concentration, the blue copper peptide and Platycladus orientalis extract are first diluted to prepare blue copper peptide sample solution and Platycladus orientalis extract sample solution, and then the blue copper peptide sample solution and Platycladus orientalis extract sample solution are added to the DMEM used for cell culture at the above concentration.

[0090] The experimental results are as follows Figure 1 As shown, based on the treatment of the compound formula, the gene targets that affect hair loss, such as FGF, VEGF, KRT, etc., all have significantly increased expression; and the inflammatory factor IL6 is significantly inhibited, which can further slow down the aging of scalp and hair.

[0091] 2. Cell Proliferation Assay (1) Cell proliferation experiment of human keratinocytes (HaCaT) This experiment uses the cell counting kit CCK-8 for determination. Human keratinocytes (HaCaT) were seeded in a 96-well plate at a density of 10 per well. 4 The cells were cultured at 25°C for 12h, 24h, and 36h, wherein the concentration of the blue copper peptide was 100, 200, and 400ppm, and the cells treated with DMEM were used as controls. The proliferation effect of the blue copper peptide on HaCaT was determined by an ELISA instrument. In this experiment, water was used as a diluent to prepare a blue copper peptide sample solution. When the blue copper peptide sample solution was used at the above concentration, the blue copper peptide sample solution was added to the DMEM used for cell culture according to the matching amount.

[0092] Test results such as Figure 2 As shown in the figure, the cell proliferation effect of HaCaT treated with blue copper peptide is obvious, proving that it has the effect of promoting hair growth. At the same concentration, from left to right, the test results at 12h, 24h and 36h are respectively represented.

[0093] (2) Cell proliferation experiment of dermal papilla cells The cell counting kit CCK-8 was used for the assay. Dermal papilla cells were seeded in a 96-well plate at a density of 10 cells per well. 4 The cells were cultured at 25°C for 12 h, 24 h, and 36 h, and the proliferation of dermal papilla cells was measured using an ELISA instrument.

[0094] In this experiment, water was used as a diluent to prepare Platycladus orientalis extract sample solution, blue copper peptide sample solution and combination sample solution. When Platycladus orientalis extract sample solution, blue copper peptide sample solution and combination sample solution were used at specific concentrations, Platycladus orientalis extract sample solution, blue copper peptide sample solution and combination sample solution were added to DMEM used for cell culture according to the matching amount, and the relevant concentrations were as follows: A blank control group was set up, in which no blue copper peptide and Platycladus orientalis extract were added; a positive control group was set up, in which fetal bovine serum was added at a concentration of 10%, and the mixed amount was added to DMEM used for cell culture; a Platycladus orientalis extract sample liquid group was set up, and the concentrations were prepared to be 2.2, 1.1, 0.55, and 0.275wt%; a blue copper peptide sample liquid group was set up, and the concentrations were prepared to be 30, 60, and 120ppm; a combination sample liquid group was set up, and a 0.1375wt% Platycladus orientalis extract-15ppm blue copper peptide group, a 0.275wt% Platycladus orientalis extract-30ppm blue copper peptide group, and a 0.55wt% Platycladus orientalis extract-60ppm blue copper peptide group were prepared.

[0095] The test results of the Platycladus orientalis extract sample are as follows Figure 3 As shown, the test results of the blue copper peptide sample solution are as follows Figure 4 As shown, the test results of the composite sample solution are as follows Figure 5 As shown; Figure 5 In the experiment, 2.5% represents 0.1375wt% Platycladus orientalis extract-15ppm blue copper peptide group, 5% represents 0.275wt% Platycladus orientalis extract-30ppm blue copper peptide group, and 10% represents 0.55wt% Platycladus orientalis extract-60ppm blue copper peptide group; compared with the blank control group, the cell viability of the positive control group increased significantly, indicating that the experimental system is effective; compared with the blank control group, Platycladus orientalis and blue copper peptide sample liquid both have the ability to promote cell proliferation at a certain concentration and have a repair effect; the concentration in the compound is 60ppm blue copper peptide + 0.55% concentration Platycladus orientalis extract, which has the proliferation ability of a single component at a high concentration, proving that the product effect is excellent and the synergistic effect is obvious. In the present invention, the concentration in the compound can also be 600ppm blue copper peptide + 5.5% concentration Platycladus orientalis extract, which has a better effect.

[0096] 3. Subcutaneous angiogenesis experiment C57BL / 6 mice were used to establish a testosterone-induced hair loss model. The hair on the back of the mice was shaved with an electric shaver. At this time, the hair was in the resting phase and the skin of the hairless mice appeared pink. The mice were randomly divided into two groups: a control group and an experimental group. Testosterone solution (0.05% dissolved in 75% ethanol) was topically applied once a day to the shaved area on the back of all mice except the control group, with 250 μL applied each time. After 30 minutes of testosterone treatment, 1000 μL of blue copper peptide sample solution was evenly applied to the shaved back. After 30 days of application, the mice were euthanized and the back dermis tissue was stained with H&E and photographed. The concentration of blue copper peptide sample solution in this experiment was 600 ppm, and the diluent was water.

[0097] Test results such as Figure 6 As shown, compared with the control group, new blood vessels with red blood cells can be seen in the dermis of mice treated in the experimental group, located at the position indicated by the arrow in the figure.

[0098] 4. α-Reductase Experimental Protocol The experimental model is type II 5α-reductase, which has been proven to induce hair loss by reducing the testosterone content in the body, which is an internal cause. Add the corresponding concentration of experimental components to a 2.5mg / mL testosterone solution and mix them. Add 80U of 5α-reductase to reduce testosterone. After the reaction is complete, high performance liquid chromatography (HPLC) is used to determine the change in the amount of substrate testosterone in the enzymatic reaction, which reflects the degree of inhibition of enzyme activity by each experimental component.

[0099] In this experiment, water was used as a diluent to prepare the Platycladus orientalis extract sample solution, the blue copper peptide sample solution and the combination sample solution. The Platycladus orientalis extract sample solution, the blue copper peptide sample solution and the combination sample solution were used at specific concentrations, and the relevant concentrations are as follows: A blank control group was set up, in which no blue copper peptide and Platycladus orientalis extract were added; a negative control group was set up, in which finasteride was added at a concentration of 1 μmol / L, and the solvent was water; a Platycladus orientalis extract sample liquid group was set up, and the concentrations were prepared to be 22, 5.5, and 2.75wt%; a blue copper peptide sample liquid group was set up, and the concentrations were prepared to be 6, 60, and 600ppm; a combination sample liquid group was set up, and the concentrations of 2.75wt% Platycladus orientalis extract-300ppm blue copper peptide group, 5.5wt% Platycladus orientalis extract-600ppm blue copper peptide group and 11wt% Platycladus orientalis extract-1200ppm blue copper peptide group were prepared.

[0100] The test results of the Platycladus orientalis extract sample are as follows Figure 7 As shown, sample 1 is a sample of Platycladus orientalis extract; the test results of the blue copper peptide sample are as follows Figure 8 As shown, sample 2 is a blue copper peptide sample solution; the test results of the combined sample solution are as follows Fig. 9As shown, sample 3 is a mixture of sample 1 and sample 2; wherein, complete reaction means that the determined 80U activity of 5-α reductase reacts with the specified concentration of testosterone solution, and after the complete reaction, some testosterone is still left to be detected. Under the experimental conditions, the compound product, in particular, has a better testosterone reduction efficiency than finasteride, proving that it has the effect of preventing testosterone loss.

[0101] 5. Oil control experiment The evaluation was based on immortalized human sebaceous gland cells SZ95. The hormone substance 5αDHT was used to stimulate and establish an in vitro oil secretion model. After drug administration, the oil control effect of the test substance was evaluated by qualitative analysis. The amount of lipid droplets was determined by detecting the fluorescence intensity, and the distribution of lipid droplets before and after the sample was treated was detected.

[0102] In this experiment, water was used as a diluent to prepare Platycladus orientalis extract sample solution, blue copper peptide sample solution and combination sample solution. When Platycladus orientalis extract sample solution, blue copper peptide sample solution and combination sample solution were used at specific concentrations, Platycladus orientalis extract sample solution, blue copper peptide sample solution and combination sample solution were added to DMEM used for cell culture according to the matching amount, and the relevant concentrations were as follows: A blank control group was set up, in which no blue copper peptide and Platycladus orientalis extract were added; a positive control group was set up, in which retinoic acid was added at a concentration of 3 μg / mL, and the mixed amount was added to DMEM used for cell culture; a Platycladus orientalis extract sample liquid group was set up, and the concentrations were prepared to be 2.2, 1.1, 0.55, and 0.275wt%; a blue copper peptide sample liquid group was set up, and the concentrations were prepared to be 30, 60, and 120ppm; a combination sample liquid group was set up, and a 0.1375wt% Platycladus orientalis extract-15ppm blue copper peptide group, a 0.275wt% Platycladus orientalis extract-30ppm blue copper peptide group, and a 0.55wt% Platycladus orientalis extract-60ppm blue copper peptide group were prepared.

[0103] The test results of the Platycladus orientalis extract sample are as follows Fig.10 As shown, the test results of the blue copper peptide sample solution are as follows Fig.11 As shown, the test results of the composite sample solution are as follows Fig.12 As shown, 2.5 represents the 0.1375wt% Thuja orientalis extract-15ppm blue copper peptide group, 5 represents the 0.275wt% Thuja orientalis extract-30ppm blue copper peptide group, and 10 represents the 0.55wt% Thuja orientalis extract-60ppm blue copper peptide group; compared with the BC group, the fluorescence intensity of the NC group was significantly increased, indicating that the induced stimulation was effective; both blue copper peptide and Thuja orientalis extract had different degrees of oil control effect, and the compound formula still had oil control effect at lower concentrations of 2.5%, 5%, and 10%, proving that the compound effect was good.

[0104] 6. Skin penetration test Intact hairless mouse skin was mounted in a Franz diffusion cell with the epidermis side facing the donor chamber. The receptor chamber was filled with HEPES buffer (10 mM, pH 7.4) mixed with 15% ethanol containing PMSF and PNT (final concentrations of 5 mM and 1 mM, respectively) as proteolytic inhibitors. 1 ml of Cu-GHK or liposome microparticle-encapsulated blue copper peptide (Cu-GHK@LP) solution was added to the donor chamber. The skin was removed from the diffusion cell 24 hours after sample preparation. The donor solution remaining on the skin surface was removed by washing with 1 ml of distilled water (repeated 4 times). The skin was dried using lint-free absorbent wipes. The stratum corneum was carefully collected using a blunt spatula. The epidermis was separated from the dermis using a blunt knife. Each separated skin layer (stratum corneum, epidermis, and dermis) was minced using scissors. Cu-GHK or Cu-GHK@LP distributed in each skin layer was extracted using 1 ml of methanol with continuous shaking for 24 hours. After 24 hours of extraction, the samples were centrifuged and the supernatant was analyzed by LC-MS / MS to assess the amount of peptides retained in the skin layer.

[0105] In this experiment, Cu-GHK@LP is the blue copper peptide liposome prepared in Example 1, Cu-GHK is the blue copper peptide, and the diluents of Cu-GHK and the blue copper peptide liposome are both water, which is used after being diluted to a specific concentration.

[0106] Test results such as Fig.13 As shown, conventional blue copper peptide can stay in the stratum corneum during application and is extremely difficult to penetrate. The content in the epidermis is extremely low, and no blue copper peptide is found in the dermis. The transdermal absorption of liposome-encapsulated blue copper peptide is about 15 times that of conventional blue copper peptide, and can reach the dermis at the highest.

[0107] The products prepared in each embodiment and comparative example of the present invention were subjected to the above-mentioned skin penetration test, and the content of blue copper peptide in the dermis was measured. The test results are as follows: Fig.14As shown, in the technical scheme of Comparative Example 1, the blue copper peptide cannot reach the dermis of the skin. In the present invention, after the core material including the blue copper peptide is directly encapsulated by polyglycerol fatty acid ester as an encapsulation material, a thickener is also required as an encapsulation material. The thickener can not only make the liposome easy to shape, but also form a composite structure with the polyglycerol fatty acid ester. After being applied to the skin penetration experiment, the blue copper peptide can be better absorbed under the skin and the amount reaching the dermis can be increased; in the process of preparing liposomes, it is found that the amount of polyglycerol fatty acid ester and blue copper peptide is within a certain range, and only then can it have a better skin penetration effect. If the amount of polyglycerol fatty acid ester is too high or too low, the skin penetration effect of the blue copper peptide will be poor; further, the present invention also finds that after butyl butyryl lactylate and polyglycerol fatty acid ester are mixed together to form a polyglycerol fatty acid ester solution, the prepared liposome has a better skin penetration effect. At the same time, after the amount of butyl butyryl lactylate is tested, it is found that the amount of butyl butyryl lactylate cannot be too high or too low, otherwise the use of butyl butyryl lactylate will not improve the skin penetration effect of the liposome.

[0108] 7. Human Experiments (1) The experiment was conducted according to the method of the National Medical Products Administration's "Notice on Incorporating 7 Test Methods Including Test Methods for Preservatives in Cosmetics into the Cosmetics Safety Technical Specifications (2015 Edition) (No. 17, 2021)" The compound formula used in this example is: water is used as a diluent to prepare a complex sample solution, which is compounded to 5.5wt% of Platycladus orientalis extract-600ppm of blue copper peptide group, where the blue copper peptide is the actual effective concentration in the blue copper peptide liposome.

[0109] In this experiment, a combination of blue copper peptide liposomes and Platycladus orientalis extract was used to conduct experiments to measure the effects of being mild and non-irritating, tightening, thickening hair diameter, increasing the number of hair in the growth phase, and reducing the number of hair in the resting phase.

[0110] Experimental method: 30 healthy male or female subjects with fine and soft hair, severe hair loss or mild hair thinning, with more than 10 hairs lost by 60 combing strokes and still more than 10 hairs after a 2-week washing period, were used to test samples, and the cosmetics were evaluated through instrumental detection, image analysis and clinical evaluation.

[0111] Evaluation indicators: Hair diameter (μm): the thickness of the hair in the measured area; Anagen / telogen hair ratio: From dermoscopic images two days after the hair was shaved, the ratio of the anagen phase to the telogen phase was calculated based on the principle that hair in the telogen phase does not grow but hair in the anagen phase grows.

[0112] Measuring area, shaved area: occipital bone, approximately 2 cm diameter circle.

[0113] Measuring instrument: Analytical management system Photo Max PRO (DMS, Austria).

[0114] The test results of hair diameter are as Fig.15 shown. After continuous use of the test sample for 4 weeks, there was no significant change in the hair diameter of the subjects compared with the baseline value (p > 0.05); after continuous use of the test sample for 8 weeks, there was no significant change in the hair diameter of the subjects compared with the baseline value (p > 0.05); after continuous use of the test sample for 12 weeks, there was a significant increase in the hair diameter of the subjects compared with the baseline value (0.01 < p ≤ 0.05), and the increase rate was 5.80%.

[0115] The test results of the proportion of anagen hair are as Fig.16 shown. After continuous use of the test sample for 4 weeks, there was a very significant increase in the proportion of anagen hair of the subjects compared with the baseline value (0.001 < p ≤ 0.01), and the increase rate was 9.23%; after continuous use of the test sample for 8 weeks, there was a very significant increase in the proportion of anagen hair of the subjects compared with the baseline value (0.001 < p ≤ 0.01), and the increase rate was 13.47%; after continuous use of the test sample for 12 weeks, there was a significant increase in the proportion of anagen hair of the subjects compared with the baseline value (0.01 < p ≤ 0.05), and the increase rate was 16.09%.

[0116] The test results of the proportion of telogen hair are as Fig.17 shown. After continuous use of the test sample for 4 weeks, there was a very significant decrease in the proportion of telogen hair of the subjects compared with the baseline value (0.001 < p ≤ 0.01), and the decrease rate was 8.72%; after continuous use of the test sample for 8 weeks, there was a significant decrease in the proportion of telogen hair of the subjects compared with the baseline value (0.01 < p ≤ 0.05), and the decrease rate was 12.09%; after continuous use of the test sample for 12 weeks, there was a significant decrease in the proportion of telogen hair of the subjects compared with the baseline value (0.01 < p ≤ 0.05), and the decrease rate was 15.20%.

[0117] In summary, after continuous use of the test product containing copper tripeptide and Platycladus orientalis extract for 4 weeks, it has the effects of increasing anagen hair, reducing telogen hair, being mild and non-irritating, and firming; after continuous use of the test product containing copper tripeptide and Platycladus orientalis extract for 8 weeks, it has the effects of increasing anagen hair and reducing telogen hair; after continuous use of the test product containing copper tripeptide and Platycladus orientalis extract for 12 weeks, it has the effects of thickening hair diameter, increasing anagen hair, and reducing telogen hair.

[0118] (2) Experiments were conducted in accordance with the test method for the anti-hair loss efficacy of cosmetics in Chapter 8.6 of the "Technical Specifications for Cosmetics Safety" (2015 edition). The compound formula used in this example is: water is used as a diluent to prepare a complex sample solution, which is compounded to 5.5wt% of Platycladus orientalis extract-600ppm of blue copper peptide group, where the blue copper peptide is the actual effective concentration in the blue copper peptide liposome.

[0119] Hair loss count: During each visit, trained staff combed the subject's hair 60 times, counted the lost hair, and recorded it.

[0120] Hair density assessment: Local assessment: A haircut area of ​​at least 1.5 cm × 1.5 cm (temporal side of the top of the head) is fixed on the subject's head and positioned properly. During each visit, the haircut area is kept consistent and the hair is cut to a residual length of no more than 1 mm. During image acquisition, the operator needs to put the subject in a comfortable position and place the dermatoscope in the center of the haircut area to take local hair images. During the shooting, the dermatoscope lens is completely in contact with the scalp and kept vertical, and the clarity of the captured image is checked. Use image analysis software or manual counting methods to count the number and density of local hair and record them.

[0121] Table 1 Difference in hair loss counts before and after product use (mean ± standard deviation)

[0122] Table 2 Local hair density before and after product use (mean ± standard deviation)

[0123] According to the above test results, the difference in hair loss counts at the 12th week after using the product was significantly lower than that of the control group (p < 0.05), and the local hair density increased significantly at the 8th and 12th weeks after using the product (p < 0.05), indicating that the product has anti-hair loss effect.

[0124] The embodiments and / or implementation methods described above are only used to illustrate the preferred embodiments and / or implementation methods for realizing the technology of the present invention, and are not intended to limit the implementation methods of the technology of the present invention in any form. Any technical personnel in this field may make slight changes or modifications to other equivalent embodiments without departing from the scope of the technical means disclosed in the content of the present invention, but they should still be regarded as technologies or embodiments that are essentially the same as the present invention.

[0125] This article uses specific examples to illustrate the principles and implementation methods of this application. The description of the above embodiments is only used to help understand the method and its core ideas of this application. The above is only the preferred implementation method of this application. It should be pointed out that due to the limitations of textual expression and the objective existence of infinite specific structures, ordinary technicians in this technical field can make several improvements, modifications or changes without departing from the principles of this application, and can also combine the above technical features in an appropriate manner; these improvements, modifications, changes or combinations, or the direct application of the concept and technical solution of the invention to other occasions without improvement, should be regarded as the scope of protection of this application.

Claims

1. A liposome encapsulating blue copper peptide, include: A core material, wherein the core material comprises a blue copper peptide; And an encapsulating material for encapsulating the core material; the encapsulating material comprises polyglycerol fatty acid ester, and the weight ratio of blue copper peptide to polyglycerol fatty acid ester is 1:1-300.

2. A liposome encapsulating blue copper peptide according to claim 1, Features: The core material further comprises a Platycladus orientalis extract; or the encapsulating material further comprises a thickener.

3. A liposome encapsulating blue copper peptide according to claim 2, Features: The weight ratio of the Platycladus orientalis extract to the blue copper peptide is 1:0.01-1000; or, the thickener includes at least one of sclerotium gum, sodium hyaluronate and xanthan gum.

4. A liposome encapsulating blue copper peptide according to claim 2, Features: The amount of the thickener is 50-100 wt % of the polyglycerol fatty acid ester.

5. A method for preparing the liposome encapsulating the blue copper peptide according to any one of claims 1 to 4, include: Liposomes encapsulating blue copper peptide are prepared by thermal spraying a core material sample liquid and an encapsulating material sample liquid; the core material sample liquid contains blue copper peptide, the encapsulating material sample liquid contains polyglycerol fatty acid ester, and the weight ratio of blue copper peptide to polyglycerol fatty acid ester is 1:1-300.

6. A composition containing blue copper peptide liposomes, comprising the liposomes encapsulating the blue copper peptide according to claim 1.

7. A composition containing blue copper peptide liposomes according to claim 6, Features: The composition also contains an extract of Platycladus orientalis.

8. Use of the liposome encapsulating the blue copper peptide according to any one of claims 1 to 4 in the preparation of toiletries.

9. Use of the composition containing blue copper peptide liposomes according to any one of claims 6-7 in the preparation of toiletries.

Citation Information

Patent Citations

  • Composition and preparation method and application thereof

    CN110151592A

  • Freeze-dried powder capable of rapidly generating blue copper peptide and preparation method thereof

    CN112603844A

  • Liquid phase synthesis method of palmitoyl tripeptide-1

    CN114891063A

  • Traditional Chinese medicine washing and caring liquid for improving sub-health state of scalp and hair as well as preparation method and application of traditional Chinese medicine washing and caring liquid

    CN115590793A

Cited By

  • Anti-hair loss shampoo containing active peptide

    CN119638787A